PLoS ONE (Jan 2018)

Diagnostic value of partial exome sequencing in developmental disorders.

  • Laura Gieldon,
  • Luisa Mackenroth,
  • Anne-Karin Kahlert,
  • Johannes R Lemke,
  • Joseph Porrmann,
  • Jens Schallner,
  • Maja von der Hagen,
  • Susanne Markus,
  • Sabine Weidensee,
  • Barbara Novotna,
  • Charlotte Soerensen,
  • Barbara Klink,
  • Johannes Wagner,
  • Andreas Tzschach,
  • Arne Jahn,
  • Franziska Kuhlee,
  • Karl Hackmann,
  • Evelin Schrock,
  • Nataliya Di Donato,
  • Andreas Rump

DOI
https://doi.org/10.1371/journal.pone.0201041
Journal volume & issue
Vol. 13, no. 8
p. e0201041

Abstract

Read online

Although intellectual disability is one of the major indications for genetic counselling, there are no homogenous diagnostic algorithms for molecular testing. While whole exome sequencing is increasingly applied, we questioned whether analyzing a partial exome, enriched for genes associated with Mendelian disorders, might be a valid alternative approach that yields similar detection rates but requires less sequencing capacities. Within this context 106 patients with different intellectual disability forms were analyzed for mutations in 4.813 genes after pre-exclusion of copy number variations by array-CGH. Subsequent variant interpretation was performed in accordance with the ACMG guidelines. By this, a molecular diagnosis was established in 34% of cases and candidate mutations were identified in additional 24% of patients. Detection rates of causative mutations were above 30%, regardless of further symptoms, except for patients with seizures (23%). We did not detect an advantage from partial exome sequencing for patients with severe intellectual disability (36%) as compared to those with mild intellectual disability (44%). Specific clinical diagnoses pre-existed for 20 patients. Of these, 5 could be confirmed and an additional 6 cases could be solved, but showed mutations in other genes than initially suspected. In conclusion partial exome sequencing solved >30% of intellectual disability cases, which is similar to published rates obtained by whole exome sequencing. The approach therefore proved to be a valid alternative to whole exome sequencing for molecular diagnostics in this cohort. The method proved equally suitable for both syndromic and non-syndromic intellectual disability forms of all severity grades.